Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Bharti Mangla"'
Autor:
Shamama Javed, Bharti Mangla, Muhammad H. Sultan, Yosif Almoshari, Durgaramani Sivadasan, Saad S. Alqahtani, Osama A. Madkhali, Waquar Ahsan
Publikováno v:
Heliyon, Vol 10, Iss 9, Pp e29783- (2024)
The issue of poor solubility of active pharmaceutical ingredients (APIs) has been a salient area of investigation and novel drug delivery systems are being developed to improve the solubility of drugs, enhance their permeability and thereby their eff
Externí odkaz:
https://doaj.org/article/4429975cf3d34752b709afa1aa6908df
Autor:
Pankaj Kumar, Bharti Mangla, Shamama Javed, Waquar Ahsan, Pankaj Musyuni, Durgaramani Sivadasan, Saad S. Alqahtani, Geeta Aggarwal
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Breast cancer being one of the most frequent cancers in women accounts for almost a quarter of all cancer cases. Early and late-stage breast cancer outcomes have improved dramatically, with considerable gains in overall survival rate and disease-free
Externí odkaz:
https://doaj.org/article/34b3c305b38543a59f4c0f3036cd5651
Autor:
Pankaj Kumar, Bharti Mangla, Sarwar Beg, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Waleed H. Almalki, Shehla Nasar Mir Najib Ullah, Geeta Aggarwal
Publikováno v:
Arabian Journal of Chemistry, Vol 15, Iss 12, Pp 104333- (2022)
Gefitinib (GFB) is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used primarily to treat non-small cell lung cancer (NSCLC), but it also works by lowering AKT and MAPK phosphorylation, which makes it effective against the breas
Externí odkaz:
https://doaj.org/article/5843b9484ee54470a9d21084ab5c98bf
Autor:
Geeta Aggarwal, Bharti Mangla, Pankaj Kumar, Shamama Javed, Waquar Ahsan, Pankaj Musyuni, Aarif Ahsan
Publikováno v:
Recent Patents on Anti-Cancer Drug Discovery. 18:448-469
Background: Gefitinib, a tyrosine kinase inhibitor, is effectively used in the targeted treatment of malignant conditions. It suppresses the signal transduction cascades leading to cell proliferation in the tumors and is now currently approved in sev
Autor:
Neha Tyagi, Priya Gupta, Zafar Khan, Yub Raj Neupane, Bharti Mangla, Nikita Mehra, Tanya Ralli, Abdulsalam Alhalmi, Asgar Ali, Omkulthom Al Kamaly, Asmaa Saleh, Fahd A. Nasr, Kanchan Kohli
Publikováno v:
Molecules, Vol 28, Iss 5, p 2343 (2023)
In the emerging field of nanomedicine, nanoparticles have been widely considered as drug carriers and are now used in various clinically approved products. Therefore, in this study, we synthesized superparamagnetic iron-oxide nanoparticles (SPIONs) v
Externí odkaz:
https://doaj.org/article/c357a2a238bd45ce8f0852b162a7c4cc
Autor:
Bharti Mangla, Sarwar Beg, Ozair Alam, Waquar Ahsan, Anzarul Haque, Kuldeep Singh Patel, Waleed Hassan Almalki, Majed Alrobaian, Kanchan Kohli
Publikováno v:
Arabian Journal of Chemistry, Vol 13, Iss 11, Pp 7909-7920 (2020)
Tamoxifen (TAM) and Sulphoraphane (SFN) are well-known anti-estrogen drugs used for the treatment of breast cancer. Due to their synergistic therapeutic potential, their combination is preferred as it helps to minimize the drug-related toxicities and
Externí odkaz:
https://doaj.org/article/53a75c5de76944ba88c53aaca9d744f3
Autor:
Bharti Mangla, Shamama Javed, Muhammad H. Sultan, Waquar Ahsan, Geeta Aggarwal, Kanchan Kohli
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Drug delivery using oral route is the most popular, convenient, safest and least expensive approach. It includes oral transmucosal delivery of bioactive compounds as the mucosal cavity offers an intriguing approach for systemic drug distribution. Owi
Externí odkaz:
https://doaj.org/article/9a6d73f36ead4ab6b1f4c0f6bdaca1d5
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2517 (2022)
Background: Quercetin (QCT) is a natural polyphenolic flavonoid showing great potential in the treatment of skin cancer. However, its use is limited owing to its poor water solubility, poor absorption, quick metabolism and excretion, as well as low s
Externí odkaz:
https://doaj.org/article/a4f024a1ee00480cb5f62ee11b875b06
Autor:
Waquar Ahsan, Hassan A. Alhazmi, Kuldeep Singh Patel, Bharti Mangla, Mohammed Al Bratty, Shamama Javed, Asim Najmi, Muhammad Hadi Sultan, Hafiz A. Makeen, Asaad Khalid, Syam Mohan, Manal M. E. Taha, Shahnaz Sultana
Publikováno v:
Frontiers in Public Health, Vol 8 (2020)
Severe acute respiratory syndrome coronavirus (CoV)-2 (SARS-CoV-2), previously called 2019 novel CoV, emerged from China in late December 2019. This virus causes CoV disease-19 (COVID-19), which has been proven a global pandemic leading to a major ou
Externí odkaz:
https://doaj.org/article/8c982ee27e8b4d928b3bd02a026cfc52
Autor:
Virender Kumar, Yogesh Kumar, Rajat Huria, Suryadev Kumar, Tarun Kalson, Deepak Jangra, Davinder Kumar, Bharti Mangla
Publikováno v:
Coronaviruses.
Background: A worldwide outbreak of respiratory illnesses has been caused by coronavirus disease (COVID-19). Traditional healers have used herbs and dietary plants for centuries to treat various conditions. This review discusses the prevention of COV